Upon entering tumor cells, drug molecules induce considerable ROS production, which triggers the AHR/glycogen phosphorylase/glycogenolysis/PPP pathway, leading to NADPH generation and subsequent ROS clearance as well as drug resistance. Here, AHR is linked to neoplasm.